GVK grants US researchers access to biomarker database
Indian contract research organisation (CRO) GVK Biosciences has signed a deal allowing pharmaceutical researchers across the US to access its clinical biomarker database.
Archives for June 8, 2011
Aurobindo Pharma gets US FDA OK for alprazolam extended-release
Drug maker Aurobindo Pharma has been cleared to make a generic equivalent of Pfizer’s CNS drug Xanax XR by the US FDA.
Unilife says device selected for new biologic trial
Unilife says its one of its technologies has been selected as the delivery device for a biologic drug in an upcoming clinical trial.
Q1 fall in number of trials in Russia a ‘blip,’ says Synergy Research
The fall in the number of trials conducted in Russia in Q1 is a ‘temporary blip’ says Synergy Research Group general manager Igor Stefanov, who cites recent changes to the approval process, rather than a drop in demand, as the key factor.
Pfizer begins ‘virtual’ trial and calls for innovation in research
Pfizer has begun what it claims is the world’s first ‘virtual’ trial and says that such innovation is needed to make sure clinical research is sustainable.
Hovione and PSI team on poorly soluble APIs
Portugal-headquartered API manufacturer Hovione has teamed up with Particle Sciences (PSI) to tackle the issue of poor drug solubility.
CMO Senn Chemicals sets up in Silicon Valley
CMO Senn Chemicals has set up a new office in California, US in a bid to streamline its operations on the West coast.